Torbenson MS - Search Results

1

Controlled HIV viral replication, not liver disease severity associated with low bone mineral density in HIV/HCV co-infection.

El-Maouche D, Mehta SH, Sutcliffe C, Higgins Y, Torbenson MS, Moore RD, Thomas DL, Sulkowski MS, Brown TT. El-Maouche D, et al. Among authors: torbenson ms. J Hepatol. 2011 Oct;55(4):770-6. doi: 10.1016/j.jhep.2011.01.035. Epub 2011 Feb 19. J Hepatol. 2011. PMID: 21338640 Free PMC article.

2

Severity and correlates of liver disease in hepatitis C virus-infected injection drug users.

Rai R, Wilson LE, Astemborski J, Anania F, Torbenson M, Spoler C, Vlahov D, Strathdee SA, Boitnott J, Nelson KE, Thomas DL. Rai R, et al. Hepatology. 2002 May;35(5):1247-55. doi: 10.1053/jhep.2002.33151. Hepatology. 2002. PMID: 11981775

3

Occult hepatitis B.

Torbenson M, Thomas DL. Torbenson M, et al. Lancet Infect Dis. 2002 Aug;2(8):479-86. doi: 10.1016/s1473-3099(02)00345-6. Lancet Infect Dis. 2002. PMID: 12150847 Review.

4

Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: a systematic review.

Gebo KA, Chander G, Jenckes MW, Ghanem KG, Herlong HF, Torbenson MS, El-Kamary SS, Bass EB. Gebo KA, et al. Among authors: torbenson ms. Hepatology. 2002 Nov;36(5 Suppl 1):S84-92. doi: 10.1053/jhep.2002.36817. Hepatology. 2002. PMID: 12407580 Review.

5

Treatment of chronic hepatitis C: a systematic review.

Chander G, Sulkowski MS, Jenckes MW, Torbenson MS, Herlong HF, Bass EB, Gebo KA. Chander G, et al. Among authors: torbenson ms. Hepatology. 2002 Nov;36(5 Suppl 1):S135-44. doi: 10.1053/jhep.2002.37146. Hepatology. 2002. PMID: 12407587 Review.

6

Role of liver biopsy in management of chronic hepatitis C: a systematic review.

Gebo KA, Herlong HF, Torbenson MS, Jenckes MW, Chander G, Ghanem KG, El-Kamary SS, Sulkowski M, Bass EB. Gebo KA, et al. Among authors: torbenson ms. Hepatology. 2002 Nov;36(5 Suppl 1):S161-72. doi: 10.1053/jhep.2002.36989. Hepatology. 2002. PMID: 12407590 Review.

7

Three-dimensional reconstruction of hepatic bridging fibrosis in chronic hepatitis C viral infection.

Hoofring A, Boitnott J, Torbenson M. Hoofring A, et al. J Hepatol. 2003 Nov;39(5):738-41. doi: 10.1016/s0168-8278(03)00413-6. J Hepatol. 2003. PMID: 14568255

8

High prevalence of occult hepatitis B in Baltimore injection drug users.

Torbenson M, Kannangai R, Astemborski J, Strathdee SA, Vlahov D, Thomas DL. Torbenson M, et al. Hepatology. 2004 Jan;39(1):51-7. doi: 10.1002/hep.20025. Hepatology. 2004. PMID: 14752822

9

Occult hepatitis B viral DNA in liver carcinomas from a region with a low prevalence of chronic hepatitis B infection.

Kannangai R, Molmenti E, Arrazola L, Klein A, Choti M, Thomas DL, Torbenson M. Kannangai R, et al. J Viral Hepat. 2004 Jul;11(4):297-301. doi: 10.1111/j.1365-2893.2004.00502.x. J Viral Hepat. 2004. PMID: 15230851

10

The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection.

Mehta SH, Thomas DL, Torbenson M, Brinkley S, Mirel L, Chaisson RE, Moore RD, Sulkowski MS. Mehta SH, et al. Among authors: torbenson m. Hepatology. 2005 Jan;41(1):123-31. doi: 10.1002/hep.20541. Hepatology. 2005. PMID: 15619237

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

321 results

Search Page

Filters